837 related articles for article (PubMed ID: 26572664)
1. Role of IgA receptors in the pathogenesis of IgA nephropathy.
Lechner SM; Papista C; Chemouny JM; Berthelot L; Monteiro RC
J Nephrol; 2016 Feb; 29(1):5-11. PubMed ID: 26572664
[TBL] [Abstract][Full Text] [Related]
2. Gluten exacerbates IgA nephropathy in humanized mice through gliadin-CD89 interaction.
Papista C; Lechner S; Ben Mkaddem S; LeStang MB; Abbad L; Bex-Coudrat J; Pillebout E; Chemouny JM; Jablonski M; Flamant M; Daugas E; Vrtovsnik F; Yiangou M; Berthelot L; Monteiro RC
Kidney Int; 2015 Aug; 88(2):276-85. PubMed ID: 25807036
[TBL] [Abstract][Full Text] [Related]
3. [Pathogenesis of Berger's disease: recent advances on the involvement of immunoglobulin A and their receptors].
Monteiro RC; Leroy V; Launay P; Moura IC; Arcos-Fajardo M; Benhamou M; Haddad E
Med Sci (Paris); 2003 Dec; 19(12):1233-41. PubMed ID: 14691748
[TBL] [Abstract][Full Text] [Related]
4. New insights in the pathogenesis of IgA nephropathy.
Monteiro RC
Nefrologia; 2005; 25 Suppl 2():82-6. PubMed ID: 16050408
[TBL] [Abstract][Full Text] [Related]
5. Food antigens and Transglutaminase 2 in IgA nephropathy: Molecular links between gut and kidney.
Abbad L; Monteiro RC; Berthelot L
Mol Immunol; 2020 May; 121():1-6. PubMed ID: 32135400
[TBL] [Abstract][Full Text] [Related]
6. [Formation of IgA deposits in Berger's disease: what we learned from animal models].
Berthelot L; Monteiro RC
Biol Aujourdhui; 2013; 207(4):241-7. PubMed ID: 24594572
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic significance of IgA receptor interactions in IgA nephropathy.
Monteiro RC; Moura IC; Launay P; Tsuge T; Haddad E; Benhamou M; Cooper MD; Arcos-Fajardo M
Trends Mol Med; 2002 Oct; 8(10):464-8. PubMed ID: 12383768
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic role of IgA receptors in IgA nephropathy.
Monteiro RC
Contrib Nephrol; 2007; 157():64-9. PubMed ID: 17495439
[TBL] [Abstract][Full Text] [Related]
9. The glomerular response to IgA deposition in IgA nephropathy.
Moura IC; Benhamou M; Launay P; Vrtovsnik F; Blank U; Monteiro RC
Semin Nephrol; 2008 Jan; 28(1):88-95. PubMed ID: 18222350
[TBL] [Abstract][Full Text] [Related]
10. Transferrin receptor engagement by polymeric IgA1 induces receptor expression and mesangial cell proliferation: role in IgA nephropathy.
Tamouza H; Vende F; Tiwari M; Arcos-Fajardo M; Vrtovsnik F; Benhamou M; Monteiro RC; Moura IC
Contrib Nephrol; 2007; 157():144-7. PubMed ID: 17495453
[TBL] [Abstract][Full Text] [Related]
11. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
Tissandié E; Morelle W; Berthelot L; Vrtovsnik F; Daugas E; Walker F; Lebrec D; Trawalé JM; Francoz C; Durand F; Moura IC; Paradis V; Moreau R; Monteiro RC
Kidney Int; 2011 Dec; 80(12):1352-63. PubMed ID: 21866091
[TBL] [Abstract][Full Text] [Related]
12. Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice.
Launay P; Grossetête B; Arcos-Fajardo M; Gaudin E; Torres SP; Beaudoin L; Patey-Mariaud de Serre N; Lehuen A; Monteiro RC
J Exp Med; 2000 Jun; 191(11):1999-2009. PubMed ID: 10839814
[TBL] [Abstract][Full Text] [Related]
13. Soluble CD89 is a critical factor for mesangial proliferation in childhood IgA nephropathy.
Cambier A; Gleeson PJ; Abbad L; Canesi F; da Silva J; Bex-Coudrat J; Deschênes G; Boyer O; Rabant M; Ulinski T; Hogan J; Peuchmaur M; Berthelot L; Monteiro RC
Kidney Int; 2022 Feb; 101(2):274-287. PubMed ID: 34756952
[TBL] [Abstract][Full Text] [Related]
14. IgA-CD89 complex in IgA nephropathy: a study on molecular function.
Wiwanitkit V
Ren Fail; 2006; 28(6):457-9. PubMed ID: 16928613
[TBL] [Abstract][Full Text] [Related]
15. Critical Role of Kupffer Cell CD89 Expression in Experimental IgA Nephropathy.
Xu L; Li B; Huang M; Xie K; Li D; Li Y; Gu H; Fang J
PLoS One; 2016; 11(7):e0159426. PubMed ID: 27437939
[TBL] [Abstract][Full Text] [Related]
16. Murine Models of Human IgA Nephropathy.
Suzuki H; Suzuki Y
Semin Nephrol; 2018 Sep; 38(5):513-520. PubMed ID: 30177023
[TBL] [Abstract][Full Text] [Related]
17. Transglutaminase is essential for IgA nephropathy development acting through IgA receptors.
Berthelot L; Papista C; Maciel TT; Biarnes-Pelicot M; Tissandie E; Wang PH; Tamouza H; Jamin A; Bex-Coudrat J; Gestin A; Boumediene A; Arcos-Fajardo M; England P; Pillebout E; Walker F; Daugas E; Vrtosvnik F; Flamant M; Benhamou M; Cogné M; Moura IC; Monteiro RC
J Exp Med; 2012 Apr; 209(4):793-806. PubMed ID: 22451718
[TBL] [Abstract][Full Text] [Related]
18. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.
Moura IC; Arcos-Fajardo M; Gdoura A; Leroy V; Sadaka C; Mahlaoui N; Lepelletier Y; Vrtovsnik F; Haddad E; Benhamou M; Monteiro RC
J Am Soc Nephrol; 2005 Sep; 16(9):2667-76. PubMed ID: 15987753
[TBL] [Abstract][Full Text] [Related]
19. Molecular Insights into the Pathogenesis of IgA Nephropathy.
Robert T; Berthelot L; Cambier A; Rondeau E; Monteiro RC
Trends Mol Med; 2015 Dec; 21(12):762-775. PubMed ID: 26614735
[TBL] [Abstract][Full Text] [Related]
20. Sparsentan ameliorates glomerular hypercellularity and inflammatory-gene networks induced by IgA1-IgG immune complexes in a mouse model of IgA nephropathy.
Reily C; Moldoveanu Z; Pramparo T; Hall S; Huang ZQ; Rice T; Novak L; Komers R; Jenkinson CP; Novak J
Am J Physiol Renal Physiol; 2024 May; 326(5):F862-F875. PubMed ID: 38511222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
